Ju Yang

8PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 30, 2025
Epigenetically-Upregulated CD98 Shed Light on the Precancerous Diagnosis and Prognosis Prediction of Esophageal Cancer.

Xue Zhang, Mengfei Sun, Na Li

|Mar 19, 2025
Clinical Characteristics, Prognostic Factors and Therapeutic Strategies in Gastric Cancer Patients With Bone Metastasis: A Retrospective Analysis.

Shiji Ren, Yutao Wei, Wenqi Liu

|Dec 20, 2023
Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer.

Qi Shi, Guixuan Xu, Yuliang Jiang

|May 19, 2023
Targeting CD44 Variant 5 with an Antibody-Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma.

Yuncheng Bei, Jian He, Xuhui Dong

|Mar 13, 2023
Real-world clinical outcomes of the combination of anti-PD-1 antibody, trastuzumab, and chemotherapy for HER2-positive gastric/gastroesophageal junction cancer.

Ju Yang, Zhan Shi, Xin Zhang

|Oct 07, 2022
DKK1 Promotes Tumor Immune Evasion and Impedes Anti-PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer.

Tao Shi, Yipeng Zhang, Yue Wang

Pageof 2

Frequent Collaborators

4 joint publications

Jia Wei

3 joint publications

Baorui Liu

2 joint publications

Xiaobin Cui

1 joint publications

Xue Zhang